Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

NCT00063076 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Targretin Gel 1%

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]